Barrow, Hanley, Mewhinney & Strauss’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.6M Buy
411,514
+64,881
+19% +$8.51M 0.16% 107
2025
Q4
$41.2M Buy
346,633
+346,474
+217,908% +$39.5M 0.14% 112
2025
Q3
$15.9K Buy
+159
New +$18.9K ﹤0.01% 179
2017
Q1
Sell
-10,317
Closed -$217K 434
2016
Q4
$217K Sell
10,317
-22,764
-69% -$434K ﹤0.01% 336
2016
Q3
$573K Buy
+33,081
New +$544K ﹤0.01% 313

Other funds holding NOVT

Barrow, Hanley, Mewhinney & Strauss's NOVT Position: Q1 2026 in Review

Barrow, Hanley, Mewhinney & Strauss increased its Novanta (NOVT) stake by 19% in Q1 2026, buying an estimated $8.51M and bringing the position to 411,514 shares worth $48.6M. The position accounts for 0.16% of the portfolio, ranked #107.

Barrow, Hanley, Mewhinney & Strauss first reported a position in NOVT in Q3 2016 and has held it in 5 quarters since. 330 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Barrow, Hanley, Mewhinney & Strauss held 411,514 shares of Novanta worth $48.6M as of Q1 2026.
  • Barrow, Hanley, Mewhinney & Strauss bought 64,881 Novanta shares in Q1 2026, an estimated $8.51M.
  • Novanta made up 0.16% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #107 holding.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Novanta in Q3 2016 and has held it in 5 quarters since.
  • 330 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.